ProQR Therapeutics (PRQR) Current Assets (2013 - 2026)

ProQR Therapeutics (PRQR) has reported Current Assets for 14 consecutive years, with $99.0 million the latest figure, recorded in Q1 2026.

• Quarterly Current Assets fell 37.01% year-over-year to $99.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.0 million (down 37.01% YoY) and the FY2025 annual result came in at $113.9 million, down 34.92% from the prior year.
• Current Assets eased to $99.0 million in Q1 2026 per PRQR's latest filing, from $113.9 million in the prior quarter.
• Over the last five years, Current Assets for PRQR reached as high as $196.3 million in Q1 2022 and fell as low as $99.0 million in Q1 2026.
• A 5-year average of $142.3 million and a median of $141.4 million in 2025 frame the typical range for Current Assets.
• The largest YoY upside for Current Assets was 236596.13% in 2022 against a maximum downside of 41.2% in 2022.
• Year by year, Current Assets stood at $175.8 million in 2022, then retreated by 21.67% to $137.7 million in 2023, then gained by 27.16% to $175.1 million in 2024, then tumbled by 34.92% to $113.9 million in 2025, then declined by 13.13% to $99.0 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $99.0 million, $113.9 million, and $126.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.